ABBV
$162.54
Revenue | $14301Mn |
Net Profits | $822Mn |
Net Profit Margins | 5.75% |
Abbvie Inc’s revenue fell -5.42% since last year same period to $14301Mn in the Q4 2023. On a quarterly growth basis, Abbvie Inc has generated 2.69% jump in its revenue since last 3-months.
Abbvie Inc’s net profit fell -66.76% since last year same period to $822Mn in the Q4 2023. On a quarterly growth basis, Abbvie Inc has generated -53.77% fall in its net profits since last 3-months.
Abbvie Inc’s net profit margin fell -64.86% since last year same period to 5.75% in the Q4 2023. On a quarterly growth basis, Abbvie Inc has generated -54.98% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 2.21 |
EPS Estimate Current Year | 2.21 |
Abbvie Inc’s earning per share (EPS) estimates for the current quarter stand at 2.21 - a -20.22% fall from last quarter’s estimates.
Abbvie Inc’s earning per share (EPS) estimates for the current year stand at 2.21.
Earning Per Share (EPS) | 2.79 |
Dividend Per Share (DPS) | 1.48 |
Abbvie Inc’s earning per share (EPS) fell -22.5% since last year same period to 2.79 in the Q4 2023. This indicates that the Abbvie Inc has generated -22.5% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Abbvie Inc declared 1.48 dividend per share during the earnings announcement for Q4 2023.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-08-07 | 2.81 | 2.91 | 3.56% |
2024-02-20 | 2.77 | 2.79 | 0.72% |
2023-05-05 | 2.46 | 2.46 | 0% |
2023-11-06 | 2.86 | 2.95 | 3.15% |